
Keywords: DRE; drug resistant epilepsy; PWE; patients with epilepsies; AEDs; anti-epileptic drugs; MTLE; mesial temporal lobe epilepsy; FCD; focal cortical dysplasia; BCRP; breast cancer resistance protein; MVP; major vault protein; MDT; smultidrug transporters; BB